Treatment  	Treatment  	 NN	O
of  	of  	 IN	O
early-stage  	early-stage  	 JJ	B-NP
erythematotelangiectatic  	erythematotelangiectatic  	 JJ	I-NP
rosacea  	rosacea  	 NN	I-NP
with  	with  	 IN	O
a  	a  	 DT	O
Q-switched  	Q-switched  	 JJ	O
595-nm  	595-nm  	 NNP	O
Nd 	Nd 	 NNP	O
: 	: 	 :	O
YAG  	YAG  	 FW	B-NP
laser  	laser  	 FW	I-NP
Erythematotelangiectatic  	Erythematotelangiectatic  	 FW	I-NP
rosacea  	rosacea  	 FW	I-NP
presents  	presents  	 VBZ	O
as  	as  	 RB	O
persistent  	persistent  	 JJ	O
erythema  	erythema  	 NN	B-NP
and  	and  	 CC	O
telangiectasia  	telangiectasia  	 NN	B-NP
with  	with  	 IN	O
frequent  	frequent  	 JJ	O
flushing  	flushing  	 NN	O
and  	and  	 CC	O
blushing  	blushing  	 NN	O
on  	on  	 IN	O
the  	the  	 DT	O
facial  	facial  	 JJ	O
and  	and  	 CC	O
extrafacial  	extrafacial  	 JJ	B-NP
skin 	skin 	 NN	I-NP
.  	.  	 .	O
Additionally 	Additionally 	 RB	O
,  	,  	 ,	O
papulopustular  	papulopustular  	 FW	B-NP
rosacea  	rosacea  	 FW	I-NP
shows  	shows  	 FW	I-NP
acneiform  	acneiform  	 FW	I-NP
papules 	papules 	 FW	I-NP
,  	,  	 ,	O
pustules 	pustules 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
nodules  	nodules  	 NN	O
with  	with  	 IN	O
persistent  	persistent  	 JJ	O
plaque-form  	plaque-form  	 JJ	B-NP
edema 	edema 	 NN	I-NP
.  	.  	 .	O
Despite  	Despite  	 IN	O
garnering  	garnering  	 VBG	O
only  	only  	 RB	O
grade-C  	grade-C  	 JJ	B-NP
or  	or  	 CC	O
-D  	-D  	 JJ	O
level  	level  	 NN	B-NP
recommendations 	recommendations 	 NNS	I-NP
,  	,  	 ,	O
a  	a  	 DT	O
585-nm  	585-nm  	 NNP	O
or  	or  	 CC	O
595-nm  	595-nm  	 CD	O
flashlamp-pumped  	flashlamp-pumped  	 JJ	O
pulsed-dye  	pulsed-dye  	 JJ	O
laser  	laser  	 NN	O
can  	can  	 MD	O
be  	be  	 VB	O
considered  	considered  	 VBN	O
as  	as  	 IN	O
an  	an  	 DT	O
effective  	effective  	 JJ	O
therapeutic  	therapeutic  	 JJ	B-NP
modality  	modality  	 NN	I-NP
for  	for  	 IN	O
the  	the  	 DT	O
treatment  	treatment  	 NN	O
of  	of  	 IN	O
rosacea  	rosacea  	 NN	B-NP
in  	in  	 IN	O
patients  	patients  	 NNS	O
who  	who  	 WP	O
are  	are  	 VBP	O
refractory  	refractory  	 VBN	O
to  	to  	 TO	O
topical  	topical  	 VB	O
and 	and 	 CC	O
/ 	/ 	 NNP	O
or  	or  	 CC	O
systemic  	systemic  	 JJ	B-NP
treatments 	treatments 	 NNS	I-NP
.  	.  	 .	O
In  	In  	 IN	O
this  	this  	 DT	O
report 	report 	 NN	O
,  	,  	 ,	O
treatment  	treatment  	 NN	O
with  	with  	 IN	O
a  	a  	 DT	O
Q-switched  	Q-switched  	 JJ	O
595-nm  	595-nm  	 FW	O
neodymium-doped  	neodymium-doped  	 FW	O
yttrium  	yttrium  	 FW	O
aluminum  	aluminum  	 FW	O
garnet  	garnet  	 FW	O
( 	( 	 -LRB-	O
Nd 	Nd 	 NNP	B-NP
: 	: 	 :	O
YAG 	YAG 	 NNP	B-NP
)  	)  	 -RRB-	O
laser  	laser  	 NN	O
with  	with  	 IN	O
low  	low  	 JJ	O
non-purpuragenic  	non-purpuragenic  	 JJ	B-NP
fluence  	fluence  	 NN	I-NP
proved  	proved  	 VBD	O
to  	to  	 TO	O
be  	be  	 VB	O
safe  	safe  	 JJ	O
and  	and  	 CC	O
effective  	effective  	 JJ	O
in  	in  	 IN	O
treating  	treating  	 VBG	B-NP
early-stage  	early-stage  	 JJ	I-NP
erythematotelangiectatic  	erythematotelangiectatic  	 JJ	I-NP
rosacea  	rosacea  	 NN	I-NP
in  	in  	 IN	O
two  	two  	 CD	O
female  	female  	 JJ	O
Korean  	Korean  	 JJ	O
patients 	patients 	 NNS	O
.  	.  	 .	O
Laser  	Laser  	 NN	O
treatment  	treatment  	 NN	O
for  	for  	 IN	O
rosacea  	rosacea  	 NN	B-NP
was  	was  	 VBD	O
delivered  	delivered  	 VBN	O
with  	with  	 IN	O
the  	the  	 DT	O
settings  	settings  	 NNS	O
of  	of  	 IN	O
pulse  	pulse  	 JJ	B-NP
energy  	energy  	 NN	I-NP
of  	of  	 IN	O
0.4-0.5  	0.4-0.5  	 NNP	O
J 	J 	 NNP	B-NP
/ 	/ 	 FW	I-NP
cm 	cm 	 FW	I-NP
( 	( 	 -LRB-	I-NP
2 	2 	 LS	I-NP
) 	) 	 -RRB-	I-NP
,  	,  	 ,	O
pulse  	pulse  	 JJ	B-NP
duration  	duration  	 NN	I-NP
of  	of  	 IN	O
5-10  	5-10  	 JJ	O
ns 	ns 	 NN	O
,  	,  	 ,	O
5-mm  	5-mm  	 CD	O
spot  	spot  	 NN	O
size 	size 	 NN	O
,  	,  	 ,	O
5  	5  	 CD	O
Hz 	Hz 	 NNP	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
500  	500  	 CD	O
shots 	shots 	 NNS	O
.  	.  	 .	O
Additionally 	Additionally 	 RB	O
,  	,  	 ,	O
we  	we  	 PRP	O
found  	found  	 VBD	O
that  	that  	 DT	O
remarkable  	remarkable  	 JJ	O
therapeutic  	therapeutic  	 JJ	B-NP
effects  	effects  	 NNS	I-NP
were  	were  	 VBD	O
achieved  	achieved  	 VBN	O
for  	for  	 IN	O
both  	both  	 DT	O
rosacea  	rosacea  	 NN	B-NP
and  	and  	 CC	O
melasma  	melasma  	 NN	B-NP
by  	by  	 IN	O
combining  	combining  	 VBG	O
Q-switched  	Q-switched  	 JJ	B-NP
quick  	quick  	 JJ	O
pulse-to-pulse  	pulse-to-pulse  	 JJ	B-NP
1,064-nm  	1,064-nm  	 NNP	O
Nd 	Nd 	 NNP	O
: 	: 	 :	O
YAG  	YAG  	 NNP	B-NP
and  	and  	 CC	O
Q-switched  	Q-switched  	 NNP	O
595-nm  	595-nm  	 NNP	O
Nd 	Nd 	 NNP	O
: 	: 	 :	O
YAG  	YAG  	 NNP	B-NP
laser  	laser  	 NN	I-NP
treatments 	treatments 	 NNS	I-NP
,  	,  	 ,	O
which  	which  	 WDT	O
required  	required  	 VBD	O
only  	only  	 RB	O
the  	the  	 DT	O
changing  	changing  	 VBG	O
of  	of  	 IN	O
handpieces  	handpieces  	 VBG	O
equipped  	equipped  	 VBN	O
with  	with  	 IN	O
solid  	solid  	 JJ	O
dye 	dye 	 NN	O
.  	.  	 .	O
In  	In  	 IN	O
conclusion 	conclusion 	 NN	O
,  	,  	 ,	O
we  	we  	 PRP	O
suggest  	suggest  	 VBP	O
that  	that  	 DT	O
treatment  	treatment  	 NN	O
with  	with  	 IN	O
a  	a  	 DT	O
Q-switched  	Q-switched  	 JJ	O
595-nm  	595-nm  	 NNP	O
Nd 	Nd 	 NNP	O
: 	: 	 :	O
YAG  	YAG  	 NNP	B-NP
laser  	laser  	 NN	I-NP
with  	with  	 IN	O
low  	low  	 JJ	O
fluence  	fluence  	 NN	B-NP
may  	may  	 MD	O
provide  	provide  	 VB	O
an  	an  	 DT	O
additional  	additional  	 JJ	O
therapeutic  	therapeutic  	 JJ	B-NP
option  	option  	 NN	I-NP
for  	for  	 IN	I-NP
treating  	treating  	 VBG	I-NP
early-stage  	early-stage  	 JJ	I-NP
erythematotelangiectatic  	erythematotelangiectatic  	 JJ	I-NP
rosacea 	rosacea 	 NN	I-NP
.  	.  	 .	O
